Scolaris Content Display Scolaris Content Display

Intracystic bleomycin for cystic craniopharyngiomas in children

This is not the most recent version

References

Additional references

Broggi 1989

Broggi G, Giorgi C, Franzini A, Servello D, Solero CL. Preliminary results of intracavitary treatment of craniopharyngioma with bleomycin. Journal of Neurosurgical Sciences 1989;33:145‐8.

Bunin 1996

Bunin GR, Surawicz TS, Witman PA, Preston‐Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. Journal of Neurosurgery 1996;89:547‐51.

DerSimonian 1986

DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7:177‐88.

Egger 1997

Egger M, Smith GD, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315:629‐34.

Gleeson 2003

Gleeson HK, Stoeter R, Ogilvy‐Stuart AL. Improvements in final height over 25 years in growth hormone (GH)‐deficient childhood survivors of brain tumors receiving GH replacement. Journal of Clinical Endocrinology & Metabolism 2003;88(8):3682‐9.

Hetelekidis 1993

Hetelekidis S, Barnes PD, Tao ML. 20‐year experience in childhood craniopharyngioma. International Journal of Radiation Oncology, Biology, Physics 1993;27(2):189‐95.

Higgins 2009

Higgins JPT, Altman DG (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. The Cochrane Collaboration, 2009.

Kremer 2010

Kremer LCM, Van Dalen EC, Moher D, Caron HN. Childhood Cancer Group. The Cochrane Library, Issue 3, 2010. Chichester: Wiley‐Blackwell. Updated monthly2010, issue 3.

Kubo 1971

Kubo O, Takakura K, Miki Y. Intracystic therapy of bleomycin for craniopharyngioma effect of bleomycin for cultured craniopharyngioma cells and intracystic concentration of bleomycin. No Shinkei Geka 1971;2:683‐8.

Mantel 1959

Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959;22:719‐48.

Mettolese 2001

Mettolese C, Stan H, HermierM. Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas. Child's Nervous System 2001;17:724‐30.

Parmar 1998

Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34.

RevMan 2008 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.

Sanford 1991

Sanford RA, Muhlbauer MS. Craniopharyngioma in children. Neurologic Clinics 1991;9:453‐65.

Slim 2003

Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non‐randomized studies (minors): development and validation of a new instrument. ANZ Journal of Surgery 2003;73(9):712‐6.

Takahashi 1985

Takahashi H, Nakazawa S, Shimura T. Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. Journal of Neurosurgery 1985;62:120‐7.

Umezawa 1966

Umezawa H, Maeda K, Takeuchi Y. New antibiotics, bleomycin A and B. Journal of Antibiotics (Tokyo) 1966;19:200‐9.

Wara 1994

Wara WM, Sneed PK, David A. The role of radiation therapy in the treatment of craniopharyngioma. Pediatric Neurosurgery 1994;21(suppl.1):98‐100.

Weiner 1994

Weiner HL, Wisoff JH, Rosenberg ME. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 1994;35:1001‐11.

Yasargil 1990

Yasargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P. Total removal of craniopharyngiomas. Approaches and long‐term results in 144 patients. Journal of Neurosurgery 1990;73:3‐11.